Near‐infrared (NIR) activatable fluorescent probes have been considered to be the effective
edge tools for the investigation of cell biology and disease diagnosis because of their …

Tumour budding is an emerging prognostic biomarker in colorectal cancer (CRC) and other
solid cancers. Tumour buds are usually defined as isolated single cancer cells or clusters of …

Tumor budding is a well-established independent prognostic factor in colorectal cancer but
a standardized method for its assessment has been lacking. The primary aim of the …

Background & Aims Colonoscopy examination does not always detect colorectal cancer
(CRC)—some patients develop CRC after negative findings from an examination. When this …

Tumor budding is a histological phenomenon encountered in various cancers, whereby
individual malignant cells and/or small clusters of malignant cells are seen in the tumor …

Tumor budding is an important additional prognostic factor for patients with colorectal cancer
(CRC). Defined as the presence of single tumor cells or small clusters of up to 5 cells in the …

Pathologically proven regional lymph node metastasis affects the prognosis in early stage
oral cancer. Therefore we investigated invasive tumor patterns predicting nodal involvement …

Tumor budding is a long-established independent adverse prognostic marker in colorectal
cancer, yet methods for its assessment have varied widely. In an effort to standardize its …

Both immune profiling and tumor budding significantly correlate with colorectal cancer
patient outcome but are traditionally reported independently. This study evaluated the …

Budding is a process during which individual or small clusters of up to five tumour cells
detach from the main tumour mass and invade into the surrounding stroma. In colorectal …